|
|
Article: Eon Labs Receives Approval for Lisinopril/HCTZ Tablets.
- Article from:
- Business Wire
- Article date:
- July 1, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business/Health Editors
Eon Labs, Inc. (Nasdaq:ELAB) announced today that it received final approval for Lisinopril/HCTZ Tablets, the generic alternative for the hypertension treatment Prinzide(R)(a).
Eon Labs approval is for the same strengths as the brand 10/12.5mg, 20/12.5mg and 20/25mg tablets. Shipments of Lisinopril/HCTZ will begin immediately. The approval of Lisinopril/HCTZ tablets is the 9th approval received by Eon Labs in 2002.
Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. Eon's diverse product line ...